Several institutions such as
Oregon Public Employees Retirement Fund and
Kesler Norman & Wride LLC have increased their holdings in
Medtronic Plc (MDT), while others like
Nisa Investment Advisors LLC and
Commonwealth Equity Services LLC reduced theirs.
Analysts also have varying views as some like
Bernstein,
Barclays, and
William Blair have raised price targets and upgraded MDT, while some indicate a bearish option is emerging despite long-term growth outlook. Medtronic’s CEO,
Geoff Martha, is scheduled to speak at the J.P. Morgan healthcare conference. The company's
Hugo Robotic System and
Symplicity Spyral have reached new milestones, moving closer to disrupting the medical device market.
Financial performance has been a mix with some citing weak financial prospects minimizing stock performance, while others note a 15.53% upside and potential strong Q2 results. Recent company initiatives such as the filing of an
IPO for its Diabetes business, MiniMed, and a recent dividend announcement showcase Medtronic's strategic maneuvers.
Medtronic Plc MDT News Analytics from Sat, 10 May 2025 07:00:00 GMT to Sat, 10 Jan 2026 15:38:47 GMT -
Rating 1
- Innovation 5
- Information 7
- Rumor 3
